Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Texas
| Provider | Medicare | Services |
|---|---|---|
| Kocs, Darren MD | $0.16 | 104.0K |
| Syed, Nayyar MD | $0.16 | 63.4K |
| Castillo, Rene MD | $0.16 | 61.3K |
| Uyeki, James M.D. | $0.16 | 53.7K |
| Shreedhara Vasudha, Meera MD | $0.16 | 51.4K |
| Agarwal, Ashwani M.D. | $0.16 | 45.8K |
| Shenkenberg, Todd M.D. | $0.16 | 44.8K |
| Rasheed, Amir M.D. | $0.16 | 44.6K |
| Hellerstedt, Beth M.D. | $0.16 | 41.2K |
| Rizvi, Akbar MD | $0.16 | 34.6K |
| Ashworth, Michelle M.D. | $0.15 | 33.0K |
| Pachipala, Krishna M.D. | $0.16 | 32.6K |
| Kodityal, Sandeep MD | $0.16 | 31.8K |
| Athar, M.A MD | $0.16 | 31.7K |
| Mohammad, Farhan M.D. | $0.16 | 31.0K |
| Le, Thuy M.D. | $0.16 | 30.3K |
| Akhtar, Syed M.D. | $0.16 | 29.3K |
| Sarhill, Nabeel MD | $0.14 | 29.1K |
| Palanisamy, Nithya MD | $0.16 | 29.0K |
| Rao, Jayasree M.D. | $0.15 | 28.8K |
| Michiels, Paul M.D. | $0.16 | 27.8K |
| Smith, Jason MD | $0.15 | 26.8K |
| Araneda, Marco M.D. | $0.16 | 25.3K |
| Illum, Henrik M.D. | $0.16 | 25.2K |
| Shaw, Andrew M.D. | $0.16 | 25.1K |
Texas Pricing in Context
In Texas, CPT code J1756 (Injection, Iron Sucrose, 1 Mg) carries an average Medicare payment of $0.16 — 0% below the national benchmark of $0.16. 743 providers across the state submitted claims for this procedure in 2023, performing 4.3M total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Texas is $1.95, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Texas lands near $0.47, with self-pay cash prices typically around $0.69. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Injection, Iron Sucrose, 1 Mg cost in Texas?
The average Medicare payment for Injection, Iron Sucrose, 1 Mg in Texas is $0.16, which is 0% below the national average of $0.16. Providers in TX typically bill $1.95 for this procedure.
What does Injection, Iron Sucrose, 1 Mg cost with insurance in Texas?
With commercial insurance in Texas, Injection, Iron Sucrose, 1 Mg costs an estimated $0.47. Without insurance, the estimated cash price is $0.69. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Injection, Iron Sucrose, 1 Mg in Texas?
743 providers in Texas billed Medicare for Injection, Iron Sucrose, 1 Mg in 2023, performing 4.3M total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Injection, Iron Sucrose, 1 Mg cheaper in Texas than the national average?
Yes — Injection, Iron Sucrose, 1 Mg costs 0% below the national average in Texas. The state average Medicare payment is $0.16 compared to $0.16 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.